you can track coronavirus Cases, deaths and testing rates at the national and state levels Here, a list of state helpline number also available.
here are the updates,
New Delhi
How Delhi Judges Helped Save People’s Lives During Corona
As we brace our head for another challenging year with a new version of Coronavirus, it is time to express our gratitude to some of our distinguished judges of the Delhi High Court, whose timely intervention has helped the collective handling of the pandemic crisis. gave a push to the efforts. during the year.
From lengthy court proceedings over the weekend to urgent late-night hearings, judges heard beyond the call of duty to helpless masses who turned to the judiciary when all else failed.
National
Omicron surge expands a central genome laboratory
The rise in coronavirus cases appears to be increasing the organizational capacity of laboratories tasked with sequencing virus genomes.
The Delhi-based National Center for Disease Control (NCDC), a Union health ministry laboratory and a key laboratory in India’s genome sequencing network, has asked states to temporarily stop sending COVID positive samples. For the past year, labs have been sending samples to NCDC to check for the presence of major strains of concern, and from December to Omicron.
America
Novavax to submit COVID-19 vaccine EUA request to US FDA next month
Novavax Inc. will submit a request next month to the US Food and Drug Administration to authorize its COVID-19 vaccine, with a further delay in submission until the end of this year.
The company’s announcement on Friday comes after it submitted to the regulator final data related to the vaccine’s manufacturing processes, which is a prerequisite for the Emergency Use Authorization Application (EUA).
Novavax has had to delay its US submission several times due to development and manufacturing failures. A report earlier this year said the methods Novavax used to test the efficacy of its vaccine fell short of regulators’ standards. Reuters
National
Amid spike, Center urges more RATs
India witnessed the highest single-day increase of 309 cases of the Omicron version of the novel coronavirus, the Union Health Ministry said on Friday, taking the number of such cases in the country to 1,270. It recorded 16,764 fresh COVID-19 cases and 220 more deaths due to the viral disease.
Taking cognizance of the increase, Union Health Secretary Rajesh Bhushan and Director General, Indian Council of Medical Research Balram Bhargava jointly wrote a letter to states to “increase testing” by employing Rapid Antigen Tests (RATs). The gold standard test for confirmation of COVID-19 is RT-PCR. However, RAT, although less accurate, gives results much faster.
National
Over 145 crore COVID vaccine doses administered in India: Govt.
India’s COVID-19 vaccination coverage crossed 145 crore on Friday, with over 52 lakh vaccine doses being administered, the Union Health Ministry said.
The daily vaccination numbers are expected to rise with the compilation of the final report for the day by late tonight.
In a tweet, Union Health Minister Mansukh Mandaviya said, “Ending the year on a grand note by crossing the milestone of 145 crore #COVID19 vaccinations. Our doctors, scientists, health care and frontline workers are blessed with immense patience, perseverance.” My gratitude for displaying resolve and resolve. In the challenging 2021 year.”- PTI
Kolkata
With rising COVID-19 cases, Kolkata to mark new containment zones
Mayor Firhad Hakim said on Friday that as the number of fresh Covid-19 infections rise, the Kolkata Municipal Corporation will mark 17 containment zones in different parts of the city.
As more than 1,000 people in the metropolis have tested positive for COVID-19, Mr Hakim told reporters, adding that the civic body will first set up ‘safe homes’ for those who cannot isolate themselves during the wave of the coronavirus pandemic. because they either lived alone. There is no caregiver or little living space.
He said that 80% of the COVID positive cases were asymptomatic, 17% had mild symptoms, while 3% required hospitalization as per the analysis to date done by the KMC and health experts. PTI
National
SII gets DCGI nod to manufacture drug substance, test it to develop jab against Omicron
India’s drug regulator on Friday approved the Serum Institute of India’s proposal to make a drug substance for the new COVID vaccine against the Omicron type of coronavirus and test and analyze it, official sources said.
The move assumes significance in the wake of the country reporting an increase in new COVID-19 cases daily, including the Omron version.
In order to conduct vaccine research against the Omicron variant, Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, recently gave a nod to the Drug Controller General of India (DCGI) to allow the manufacturing of a drug substance for SARS-CoV. Application was submitted. Recombinant spike nanoparticle vaccine (Omicron variant) for 2RS protein (COVID-l9) test test and analysis. PTI
Rajasthan Rajasthan
Will impose more restrictions in Jaipur as COVID situation can be explosive: Gehlot
Rajasthan Chief Minister Ashok Gehlot on Friday said his government would impose more restrictions to check the spread of coronavirus in state capital Jaipur as the situation could be explosive and not to be taken lightly.
In a review meeting telecasted live on social media platforms, he directed officials to increase testing in the capital.
Food and Civil Supplies Minister Pratap Singh suggested the closure of schools, while also recommending the closure of religious places and a ban on gatherings at weddings.
Jaipur had recorded 185 out of 252 positive cases on Thursday. Out of 773 active cases, 521 are in Jaipur. PTI
,